Methrotexate Treatment Inmunomodulates Abnormal Cytokine Expression by T CD4 Lymphocytes Present in DMARD-Naïve Rheumatoid Arthritis Patients
Authors:
- Jorge Monserrat SanzJorge Monserrat Sanz
- Cristina BohórquezCBCristina Bohórquez
- Ana Maria GómezAGAna Maria Gómez
- Atusa MovasatAMAtusa Movasat
- Ana PérezAPAna Pérez
- Lucía RuízLRLucía Ruíz
- David DiazDDDavid Diaz
- Ana Isabel SánchezASAna Isabel Sánchez
- Fernando AlbarránFAFernando Albarrán
- Ignacio SanzISIgnacio Sanz
- Melchor Álvarez-MonMelchor Álvarez-Mon
Open Access
- 18 September 2020
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (18) , 6847
Abstract
CD4+T-lymphocytes are relevant in the pathogenesis of rheumatoid arthritis (RA), however, their potential involvement in early RA remains elusive. Methotrexate (MTX) is a commonly used disease-modifying antirheumatic drug (DMARD), but its mechanism has not been fully established. In 47 new-onset DMARD-naïve RA patients, we investigated the pattern of IFNγ, IL-4 and IL-17A expression by naïve (TN), central (TCM), effector memory (TEM) and effector (TE) CD4+ subsets; their STAT-1, STAT-6 and STAT-3 transcription factors phosphorylation, and the circulating levels of IFNγ, IL-4 and IL-17. We also studied the RA patients after 3 and 6 months of MTX treatment and according their clinical response. CD4+T-lymphocyte subsets and cytokine expression were measured using flow cytometry. New-onset DMARD-naïve RA patients showed a significant expansion of IL-17A+, IFNγ+ and IL-17A+IFNγ+ CD4+T-lymphocyte subsets and increased intracellular STAT-1 and STAT-3 phosphorylation. Under basal conditions, nonresponder patients showed increased numbers of circulating IL-17A producing TN and TMC CD4+T-lymphocytes and IFNγ producing TN, TCM, TEM CD4+T-lymphocytes with respect to responders. After 6 months, the numbers of CD4+IL-17A+TN remained significantly increased in nonresponders. In conclusion, CD4+T-lymphocytes in new-onset DMARD-naïve RA patients show IL-17A and IFNγ abnormalities in TN, indicating their relevant role in early disease pathogenesis. Different patterns of CD4+ modulation are identified in MTX responders and nonresponders.Keywords
Funding Information
- Fondo de Investigación de la Seguridad Social, Instituto de Salud Carlos III (PI18/01726)
- Programa de Actividades de I+D de la Comunidad de Madrid en Biomedicina (S2017/BMD-3804)
This publication has 50 references indexed in Scilit:
- From a gene-centric to whole-proteome view of differentiation of T helper cell subsetsBriefings in Functional Genomics, 2013
- Frequency of Th17 CD4+ T Cells in Early Rheumatoid Arthritis: A Marker of Anti-CCP SeropositivityPLOS ONE, 2012
- Standardizing immunophenotyping for the Human Immunology ProjectNature Reviews Immunology, 2012
- The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age‐dependent mannerArthritis & Rheumatism, 2010
- The Current STATus of lymphocyte signaling: new roles for old playersCurrent Opinion in Immunology, 2009
- Clinical relevance of the severe abnormalities of the T cell compartment in septic shock patientsCritical Care, 2009
- Human interleukin 17–producing cells originate from a CD161+CD4+ T cell precursorJournal of Experimental Medicine, 2008
- T cells in rheumatoid arthritisArthritis Research & Therapy, 2008
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 1999
- Development and validation of the european league against rheumatism response criteria for rheumatoid arthritis: Comparison with the preliminary american college of rheumatology and the world health organization/international league against rheumatism criteriaArthritis & Rheumatism, 1996